Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
GPT Healthcare Limited owns and operates a chain of hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology with renal transplants; laparoscopic and general surgery; critical care; pediatrics; gastroenterology; gynecology and obstetrics; interventional cardiology; orthopedics and joint replacement; neurosciences; and others. It also operates clinics and pharmacies, as well as the ILS Agartala Nursing Institute. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.
Key Metrics
as of Sep 2026
Market Cap 1,307 Cr
P/E 31.40
Div Yield 1.58 %
Book Value β
52w High βΉ175.00
52w Low βΉ114.00
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
126.00
126.00
120.00
119.00
107.00
101.00
102.00
106.00
98.00
99.00
97.00
108.00
96.00
Expenses
102.00
103.00
99.00
96.00
90.00
81.00
81.00
82.00
80.00
76.00
76.00
83.00
77.00
Operating Profit
24.00
23.00
21.00
23.00
17.00
21.00
21.00
23.00
18.00
23.00
21.00
25.00
19.00
OPM %
19.00
18.00
17.00
19.00
16.00
20.00
21.00
22.00
18.00
23.00
22.00
23.00
20.00
Other Income
2.00
2.00
1.00
1.00
2.00
2.00
2.00
3.00
2.00
2.00
1.00
1.00
1.00
Depreciation
7.00
7.00
7.00
7.00
6.00
5.00
5.00
5.00
5.00
5.00
4.00
4.00
4.00
Interest
2.00
2.00
2.00
2.00
2.00
1.00
1.00
1.00
1.00
2.00
2.00
2.00
2.00
Profit before tax
17.00
16.00
13.00
15.00
11.00
16.00
18.00
21.00
15.00
18.00
16.00
19.00
14.00
Tax %
26.00
8.00
27.00
30.00
31.00
21.00
30.00
28.00
32.00
30.00
28.00
31.00
30.00
Net Profit
13.00
15.00
9.00
11.00
8.00
13.00
12.00
15.00
10.00
13.00
11.00
14.00
10.00
EPS in Rs
1.55
1.78
1.14
1.29
0.94
1.57
1.49
1.81
1.21
1.56
1.44
1.69
1.25
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Sales
473.00 407.00 400.00 361.00 337.00 243.00 212.00
Expenses
387.00 324.00 312.00 287.00 263.00 194.00 176.00
Operating Profit
85.00 83.00 88.00 74.00 74.00 49.00 36.00
OPM %
18.00 20.00 22.00 21.00 22.00 20.00 17.00
Other Income
5.00 8.00 5.00 6.00 5.00 6.00 4.00
Interest
8.00 3.00 7.00 9.00 11.00 14.00 14.00
Depreciation
27.00 19.00 18.00 15.00 14.00 12.00 11.00
Profit before tax
55.00 69.00 68.00 56.00 54.00 29.00 15.00
Tax %
23.00 28.00 30.00 30.00 23.00 27.00 26.00
Net Profit
42.00 50.00 48.00 39.00 42.00 21.00 11.00
EPS in Rs
5.15 6.08 5.82 4.88 5.21 11.76 6.11
Dividend Payout %
49.00 41.00 60.00 102.00 0.00 47.00 0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Equity Capital
82.00 82.00 82.00 80.00 80.00 18.00 18.00
Reserves
187.00 166.00 136.00 85.00 78.00 116.00 109.00
Borrowings
91.00 35.00 31.00 82.00 102.00 166.00 157.00
Other Liabilities
104.00 101.00 96.00 79.00 63.00 18.00 25.00
Total Liabilities
465.00 384.00 346.00 327.00 323.00 317.00 308.00
Fixed Assets
342.00 228.00 224.00 228.00 220.00 220.00 226.00
CWIP
1.00 46.00 6.00 3.00 1.00 0.00 2.00
Investments
43.00 32.00 30.00 13.00 10.00 1.00 1.00
Other Assets
79.00 78.00 85.00 83.00 92.00 97.00 80.00
Total Assets
465.00 384.00 346.00 327.00 323.00 317.00 308.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activity
81.00 67.00 69.00 66.00 66.00 43.00 41.00
Cash from Investing Activity
-47.00 -33.00 -25.00 5.00 -5.00 -16.00 -54.00
Cash from Financing Activity
-31.00 -35.00 -48.00 -73.00 -57.00 -22.00 12.00
Net Cash Flow
2.00 0.00 -5.00 -2.00 3.00 4.00 -1.00
Free Cash Flow
40.00 18.00 50.00 58.00 59.00 38.00 -5.00
CFO/OP %
110.00 101.00 95.00 103.00 107.00 88.00 116.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Debtor Days
16.00 18.00 22.00 21.00 15.00 26.00 30.00
Inventory Days
43.00 41.00 36.00 43.00 30.00 41.00 60.00
Days Payable
170.00 161.00 165.00 161.00 121.00 165.00 314.00
Cash Conversion Cycle
-112.00 -102.00 -106.00 -97.00 -76.00 -98.00 -224.00
Working Capital Days
-29.00 -28.00 -16.00 -18.00 3.00 32.00 -4.00
ROCE %
20.00 27.00 30.00 25.00 23.00 14.00 β
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Promoters
65.57
65.57
65.57
65.57
65.57
65.57
65.57
65.57
65.57
65.57
FIIs
3.03
2.81
2.73
3.20
4.96
4.49
4.71
4.70
5.38
6.68
DIIs
6.94
6.84
6.20
6.45
9.33
11.35
11.30
10.80
11.88
11.61
Public
24.46
24.79
25.48
24.77
20.14
18.59
18.41
18.92
17.16
16.14
No. of Shareholders
62,454
64,075
66,626
67,617
67,060
68,365
70,147
74,737
71,293
76,664
Corporate Actions
6 records
Back to all stocks